|
Volumn 51, Issue 2, 2012, Pages 252-253
|
Urgent patient admission to Working Group for Urological Oncology (AUO) study on metastasized renal cell carcinoma needed: Prospective randomized multicentric phase II study on resection of pulmonary metastases in clear cell renal carcinoma ± adjuvant sunitinib therapy over 1 year (SMAT - AN 20/04 of the AUO);Dringend patientenzuweisungen zu AUO-studie beim metastasierten nierenzellkarzinom gesucht: Prospektiv randomisierte multizentrische Phase-II-Studie zur metastasenresektion von lungenfiliae beim klarzelligen nieren- zellkarzinom ± adjuvante sunitinib-therapie über 1 jahr (SMAT - AN 20/04 der AUO)
a
AUO MeckEvidence
*
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HOSPITAL ADMISSION;
HUMAN;
KIDNEY CARCINOMA;
LUNG METASTASIS;
LUNG SURGERY;
NOTE;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GERMANY;
KIDNEY TUMOR;
LUNG TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PATIENT SELECTION;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
PYRROLE DERIVATIVE;
SUNITINIB;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FEMALE;
GERMANY;
HUMANS;
INDOLES;
KIDNEY NEOPLASMS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
PATIENT SELECTION;
PYRROLES;
|
EID: 84862285745
PISSN: 03402592
EISSN: 14330563
Source Type: Journal
DOI: 10.1007/s00120-012-2809-6 Document Type: Note |
Times cited : (5)
|
References (0)
|